A Trial of Placebo Versus Macrolide for Mycoplasma Pneumoniae Childhood Pneumonia: MYTHIC Study
Conditions: Community Acquired Pneumonia in Children; Mycoplasma Pneumoniae; Mycoplasma Pneumoniae Pneumonia Interventions: Drug: Azithromycin Pfizer ®; Drug: Placebo Sponsors: Christoph Berger Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 22, 2024 Category: Research Source Type: clinical trials
A Study to Learn About Dacomitinib in Patients With Non-small Cell Lung Cancer.
Conditions: Lung Cancer Sponsors: Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 20, 2024 Category: Research Source Type: clinical trials
A Study to Learn About the Study Medicine Called Tafamidis 61mg in People Diagnosed With Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
Conditions: Transthyretin Amyloid Cardiomyopathy Interventions: Drug: Tafamidis 61 milligrams Sponsors: Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 20, 2024 Category: Research Source Type: clinical trials
A Study of HR+/HER2- Metastatic Breast Cancer Patients Treated With Palbociclib Together With an Aromatase Inhibitor From 2017 to 2023 in Denmark.
Conditions: Breast Cancer Interventions: Drug: Palbociclib in combination with AI Sponsors: Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 12, 2024 Category: Research Source Type: clinical trials
A Study to Learn About the Study Medicine Bosulif in Adult Patients With Chronic Myeloid Leukemia(CML).
Conditions: Chronic Leukemia Myelogenous Interventions: Drug: Bosulif Sponsors: Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 7, 2024 Category: Research Source Type: clinical trials
A Study to Learn About the Effectiveness of Etrasimod in People With Ulcerative Colitis
Conditions: Colitis, Ulcerative Interventions: Drug: Etrasimod Sponsors: Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 6, 2024 Category: Research Source Type: clinical trials
A Study to Learn About the Use of Paxlovid in Patients With COVID-19 in the Kingdom of Bahrain.
Conditions: COVID-19 Interventions: Drug: nirmatrelvir, ritonavir; Other: Controls Sponsors: Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 4, 2024 Category: Research Source Type: clinical trials
A Study of PF-07820435 as a Single Agent and in Combination in Participants With Advanced Solid Tumors
Conditions: Neoplasms; Non-small-cell Lung Cancer; Melanoma; Squamous Cell Carcinoma of the Head and Neck; Renal Cell Carcinoma; Urothelial Carcinoma; Colorectal Carcinoma; Ovarian Carcinoma Interventions: Drug: PF-07820435; Biological: Sasanlimab Sponsors: Pfizer Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 29, 2024 Category: Research Source Type: clinical trials
Litfulo Capsules Special Investigation
Conditions: Alopecia Areata Interventions: Drug: LITFULO Sponsors: Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 28, 2024 Category: Research Source Type: clinical trials
A Study to Learn About Lorlatinib in Patients With Non-Small Cell Lung Cancer Which Could Not Be Controlled
Conditions: Non-Small Cell Lung Carcinoma Interventions: Drug: Lorlatinib Sponsors: Pfizer Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 28, 2024 Category: Research Source Type: clinical trials
A Study to Learn How Different Amounts of PF-06954522 Are Tolerated and Act in Adults With Type 2 Diabetes Mellitus
Conditions: Type 2 Diabetes Mellitus (T2DM); Obesity Interventions: Drug: Placebo; Drug: Rosuvastatin; Drug: Midazolam; Drug: Omeprazole; Drug: PF-06954522 Sponsors: Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 28, 2024 Category: Research Source Type: clinical trials
Phenotyping of Idiopathic Pelvic Pain With Real-time Uterine Imaging and Relugolix-Combination Therapy Treatment
Conditions: Pelvic Pain Interventions: Drug: Relugolix (40 mg) /estradiol (1 mg)/norethisterone acetate (0.5 mg) oral tablet Sponsors: NorthShore University HealthSystem; Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 26, 2024 Category: Research Source Type: clinical trials
A Study to Learn How Different Forms of Study Medicine Tafamidis Are Taken Up Into The Blood in Healthy Adults
Conditions: Healthy Interventions: Drug: Tafamidis 61 mg free acid tablet (Test 1); Drug: Tafamidis 70 mg free acid tablet (Test 1); Drug: Tafamidis 61 mg free acid capsule (Reference) Sponsors: Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 23, 2024 Category: Research Source Type: clinical trials
A Study to Learn If the Study Medicine Esomeprazole Changes How the Body Processes the Other Study Medicine Vepdegestrant
Conditions: Healthy Interventions: Drug: vepdegestrant; Drug: esomeprazole Sponsors: Pfizer; Arvinas Estrogen Receptor, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 23, 2024 Category: Research Source Type: clinical trials
A Study to Understand What the Body Does to the Study Medicine Called PF-07220060 When Taken by Healthy Adults
Conditions: Healthy Participants Interventions: Drug: Oral [14C]PF-07220060; Drug: Oral PF-07220060; Drug: IV [14C] PF-07220060 Sponsors: Pfizer Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 20, 2024 Category: Research Source Type: clinical trials
